
Current Price | $124.08 | Mkt Cap | $15.5B |
---|---|---|---|
Open | $122.22 | P/E Ratio | 19.80 |
Prev. Close | $122.56 | Div. (Yield) | $0.28 (0.2%) |
Daily Range | $121.68 - $124.92 | Volume | 382,485 |
52-Wk Range | $113.46 - $184.75 | Avg. Daily Vol. | 877,884 |
A provider of scientific instruments, consumables and services to the pharmaceutical, biomedical, academic research, environmental testing and general industrial markets, commonly referred to as the health sciences and photonics markets.
Current Price | $124.08 | Mkt Cap | $15.5B |
---|---|---|---|
Open | $122.22 | P/E Ratio | 19.80 |
Prev. Close | $122.56 | Div. (Yield) | $0.28 (0.2%) |
Daily Range | $121.68 - $124.92 | Volume | 382,485 |
52-Wk Range | $113.46 - $184.75 | Avg. Daily Vol. | 877,884 |
The best Bull and Bear pitches based on recency and number of recommendations.
well run company... pharma boom coming...
Serial underperformer. No clear strategy combined with confused communication. Can cut costs with the best of them and squeeze out margin improvements but can't grow the top line.
Read the most recent pitches from players about PKI.
Recs
Its COVID-19 test is considered the most sensitive on the market. Plus, the company's purchase of a cell engineering company will help it expand its pipeline.
Recs
S&P Top performer
Recs
Serial underperformer. No clear strategy combined with confused communication. Can cut costs with the best of them and squeeze out margin improvements but can't grow the top line.
Find the members with the highest scoring picks in PKI.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
ipfmanager | 98.00 | 3/19/2009 |
![]() |
5Y | $11.09 | +1,015.92% | +394.56% | +621.36 | 1 Comment | |
plcoyne | < 20 | 3/11/2009 |
![]() |
5Y | $10.84 | +1,041.25% | +448.28% | +592.97 | 0 Comment | |
MKArch | 99.77 | 3/30/2009 |
![]() |
NS | $11.56 | +970.17% | +397.98% | +572.19 | 0 Comment | |
chinnook | < 20 | 12/31/2008 |
![]() |
NS | $12.18 | +916.20% | +349.33% | +566.87 | 0 Comment | |
robglez1 | 91.77 | 1/2/2009 |
![]() |
3W | $12.34 | +902.71% | +344.36% | +558.36 | 0 Comment | |
kevinottofro | 22.33 | 4/27/2009 |
![]() |
3Y | $12.11 | +922.03% | +363.84% | +558.19 | 1 Comment | |
seniorforest | 65.81 |
|
![]() |
5Y | $12.83 | +864.11% | +339.08% | +525.03 | 0 Comment | |
3st4 | 98.32 | 1/9/2009 |
![]() |
NS | $12.83 | +864.11% | +339.08% | +525.03 | 0 Comment | |
william0509 | < 20 | 4/13/2009 |
![]() |
5Y | $12.75 | +870.65% | +367.99% | +502.65 | 0 Comment | |
Columbustaxman | 44.76 | 9/15/2006 |
![]() |
1Y | $16.60 | +645.37% | +218.46% | +426.91 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.